Open access
Oct 2026
A genome‑wide screen in E. coli reveals metabolic adaptations that enhance intratumoral fitness and bacterial cancer therapy efficacy.
It is demonstrated that adapting bacteria to the unique characteristics of the tumor metabolic microenvironment can drive the development of safer and more effective chassis for next‑generation bacterial cancer therapies.
Noah Chen, Mathieu Rouanne, Zao-Feng Yang et al.
· Nature Cancer · 0 citations